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Abstract. The tissue thromboplastin activity of porcine lung was separated from an
aqueous tissue extract by differential centrifugation. R.epeated suspension and sedimen-
tation yielded a thromboplastin preparation free of soluble protein.
The most effective delipidation of the lyophilized preparation with minimum denatu-
ration of the protein moiety of thromboplastin was achieved using z-heptaneln-butanol
extraction. A detergent was required to solubilize the thromboplastin protein moiety
from the delipidated preparation. Gel filtration in the presence of detergent permitted
further delipidation of the protein moiety and yielded a purified protein moiety. Apparent
homogeneity was observed for the purifled protein with several fractionation techniques.
This apparently homogeneous protein dissociates into the constituent proteins in the
presence of dodecyl sulphate. The aggregation of proteins is ascribed to their hydrophobic
nature. Gel filtration on Bio-Gel A-1.5 m was found to be useful in the separation of the
dodecyl sulphate-protein complexes on a preparative scale. Following the removal ofthe
dodecyl sulphate, the renaturation ofthe thromboplastin protein moiety was unsuccessful.
The purified protein moiety with its low lipid content (l%) is suitable for lipid require-
ment studies.
Introduction
The high clot-promoting activity of various tissue extracts is attributed
to the presence of tissue thromboplastin, which is the activator of the ex-
trinsic blood coagulation mechanism [18, 33]. It is bound to subcellular
Received : April 25, 197 7 ; in revised form : J uly 25, 197 7 ; accepted by editor K. LncnNen :
July 25,1977.
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particles l5-7,31,321. Thromboplastin preparations contain both lipid and
protein material. Extraction of lyophilized preparations by organic solvents
results in a loss of the high procoagulant activity, but the activity can be
restored under certain conditions by recombination of the two moieties [8,
13,17, 19,251.
With the purifled protein moiety of tissue thromboplastin, it is possible
to study the lipid requirements of the protein, the activating principle of
factor VII, the occurrence and localization of thromboplastin in tissues, its
possible release into the blood under different conditions and its fate there-
after. There have been several reports on the purification of the protein
moiety of thromboplastin derived from bovine tissue [15, 20, 2lf, canine
tissue [9] and human tissue [0, l8]. However, the procedures result in pre-
parations which are either still contaminated with other proteins, have
low solubility in aqueous media in the absence of detergent, contain too
little protein for extensive studies or contain a thromboplastin which cannot
activate human factor VII.
We have recently demonstrated that tissue thromboplastin from porcine
lung activates human factor VII, whereas that from bovine tissue does not
[30]. Therefore, porcine lung thromboplastin seems to be a suitable prepara-
tion for investigating the function of thromboplastin in the activation of
human factor VII and the lipid requirements of tissue thromboplastin. An
important advantage with respect o the purification and subsequent studies
is the ready availability of a large supply of porcine lung tissue.
In the present study, the protein fraction of porcine lung thromboplastin
was subjected to fractionation techniques which resulted in a partially
purified protein moiety. The phospholipid requirements of this protein are
described in a subsequent paper [29].
Materials and Methods
Porcine lung thromboplastiz was prepared according to the method of Cxancern er a/.
[5], with some modifications [30]. Fresh lungs were washed, cut into pieces and homo-
genized after the addition of saline. Large particles and connective tissue were removed
by centrifugation (1,250 g for l0 min) after which the supernatant was subjected to two
successive centrifugations at 2,50O g for 45 min. Thromboplastin was sedimented from the
final supernatant at 100,0009 for 60 min and suspended in borate butrer (I 0.15, pH 8,6).
This suspension was subjected to ultracentrifugation (100,000 g for 60 min) and resuspen-
sion in borate buffer 4 times. It was subSequently washed 4 times using distilled water.
This resulted in a purified thromboplastin preparation which was free of soluble proteins.
Finally, the grey-coloured pellet was lyophilized and stored at -20 "C.
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Human brain thromboplastinwas prepared from acetone-dried tissue as described by
Hrcrrr and Oosrrnrurq-V.q.N Ln [12].
Extraction of porcine lung thromboplastin. Lyophilized thromboplastin (1 g) was
extracted with r-heptane/n-butanol 2ll (vlv) (100 ml) by stirring for 30 min at room
temperature; this was followed by sedimentation for 15 min at 1,000 g. The supernatant
was used for the isolation of the phospholipids and the pellet was extracted 4 more times
with the same solvent system. The pellet was finally dried under vacuum for 16 h and
stored at -20 "C,
Gel filtration. n-Heptaneln-butanol extracted porcine lung thromboplastin (200 mg)
was solubilized in Veronal-chloride buffer (I 0.015, pH 7.35; 15 ml) containing 1 f sodium
deoxycholate by homogenization in a Potter-Elvehiem tube and by stirring for t h at
room temperature. Insoluble material was removed by sedimentation at 20,000 g for
15 min. After the addition of sucrose (500 mg) to the supernatant, the sample was placed
onto a Sephadex G-200 column (60 x 3 cm) or a Sepharose-6B column beneath an eluant
layer of 3-5 cm. The column, which has been equilibrated with 0.25 f sodium deoxycholate
in Veronal-chloride buffer (I 0.015, pH 7.35), was eluated with the same buffer at a flow
rute of 12 ml/h. Fractions of 9 ml were collected and tested for protein and phosphorus
content. A 1.0-ml volume of the fraction was dialyzed against Veronal-chloride buffer
(I 0.015, pH 7.35) for 48 h followed by the addition of 1.5 mg phospholipid mixture of
thromboplastin, solubilized in 0.5 ml acetate buffer (I 0.01, pH 4.0) containingl.S/o
sodium taurocholate. The detergent was subsequently removed by dialysis against acetate
buffer for 65-70 h as described by WrNoa.nnos et al. 1291. The recombinants were tested
for thromboplastin activity.
The remaining volumes (8 ml) of the fractions which showed thromboplastin activity
were combined , dialyzed, against Veronal-chloride buffer for about 90 h and concentrated
by dialysis against l0%, polyethylene glycol (molecular weight 20,000) in the same buffer.
The concentrated preparation (1-1.5 mg protein per millilitre) was subjected to further
purifi cation techniques.
Gel filtration in the presence of KSCN, ethanol or guanidine hydrochloride was per-
formed by adding these reagents to all solutions which were involved in the separation.
Rheomacrodex (molecular weight 40,000) was added as a l0\ solution in saline.
Sodium dodecyl sulphate polyacrylamide gel electrophoresrs lvas performed according
to the method of Snnprno et al. l24l using a Shandon Disc electrophoresis apparatus.
The electrophoresis time was 3.5 h with a constant current of 5 mA per tube. The gels
were fixed in lO% trichloroacetic acid for 16 h and stained for I h in O.25 \ Coomassie
brilliant blue R-250 dissolved in methanol/acetic acid/water 5lll5 (vlvlv). The gels were
decolourized in the same solvent system and stored in 7 \ acetic acid.
The dodecyl sulphate-protein complexes were fractionated on a preparative scale with
the same gel composition using the Buchler'Poly Prep' apparatus.
Gel filtration of dodecyl sulphate-protein complexes was performed in Veronal-chloride
buffer (I 0.015, pH 7.35) containingQ.Oz5y" sodium dodecyl sulphate on Bio-Gel A-1.5 m
at room temperature. The protein sample was incubated in the Veronal-chloride buffer
containing 1.0f sodium dodecyl sulphate for 3 h at 37 "C before application to the
column.
Isolation of phospholipids from porcine lung thromboplastin extract. The z-heptane/
z-butanol extract of 3 g of thromboplastin was evaporated and dried under reduced pres-
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sure and dissolved in 50 ml of chloroform. This solution was applied to a silicic acid
column (Mallinckrodt, analytical grade, 60-140 mesh; 17 x 4.5 cm) previously equilibrated
with chloroform. Neutral lipids were eluted with chloroform/methanol mixtures containing
5 and l0\ (v/v) methanol. This was followed by the elution of the phospholipids. For that
purpose, the methanol concentration was stepwise increased from l5 to 60\ (v/v). These
fractions were combined and evaporated and the residue was dissolved in r-pentane.
Traces of silicic acid were removed by the addition of 5 '% (vlv) of water followed by centri-
fugation for 20 min at 2,000 g at room temperature. The supernatant was evaporated and
the phosphblipid mixture was dissolved in n-pentane, which had been dried with anhydrous
sodium carbonate, and stored under nitrogen at -20 "C.
Thin-layer chromatography of phospholipids. Samples were acidified to pH 2 with HCI
and the lipids ektracted as described by Br,rcn and Dvnn [3]. The lipid extracts were
chromatographed two-dimensionally on silica gel HR to which 2f magnesium silicate
(w/w) had been added following the method of Bnorrrruvsn [4].
The spots were visualized by spraying with 20/. HrSOa and heating for 2-3 h at
180 "C. The amount of phosphorus in the spots was determined by the method of Rousrn
et al.1221.
Thromboplastin activity was estimated by the two-stage assay described elsewhere [30].
The first stage involved an incubation of purified human factor VII with the sample in the
presence of calcium chloride. The degree of activation of factor VII was subsequently
determined in a clotting system consisting of artificially depleted factor VII reagent, a
phospholipid suspension and calcium chloride. The degree of activation was found to be
directly proportional to the thromboplastin activity of the sample.
The activity was calculated from the clotting time with the aid of a standard curve and
it was expressed in percent activity with reference to an equal amount of standard recom-
binant [29].
Protein was measured by the method of Lownv et al.1161.
Phosphorus content was determined according to the method of Blnrr,nrr [l].
Results
Delipidation of Tissue Thromboplastin
Different organic solvent systems were tested for their capacity to
extract the lipids of lyophilized thromboplastin. These included n-bttanol,
petroleum ether, ether, ether/ethanol mixtures, pyridine, pyridine/chloro-
form mixtures and acetone/water at -15 "C L231.
These procedures resulted in protein fractions which still contained too
much lipid material or which did not demonstrate clot-promoting activity
after recombination with the lipid fraction [28]. In addition, the solubility
of the protein fractions in aqueous media without a detergent was very low.
Techniques employing an aqueous and an organic liquid phase always
produced protein fractions devoid of the clot-promoting property.
Porcine Tissue Thromboplastin
Table I. Protein and phosphorus content (f SD; n : 4)
of porcine lung thromboplastin (PLTP) and its fractions
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Preparation
Protein
o/
Lipid 
. 
Non-lipid
phosphorusr phosphorus
pclmc pclmc
PLTP
n-Heptane I n-butanol-extracted PLTP
Purified protein moiety of PLTP
from gel filtration on Sephadex G-200
15.7t0.3 2.93+0.81
1.73+0.03 3.95+0.06
0.42t0.08 1.69+0.21
39.9+5.6
76.9L3.8
74.0+2.2
r The phospholipid content is about 25 times that ofthe lipid phosphorus content.
Table IL Phospholipid composition of porcine lung thromboplastin (PLTP) and its fractions
Phospholipid PLTP
, o // o
n-Heptane/n-butanol Delipidated
extract ofPLTP PLTP
o /  o /
/o /o
Phospholipidpeak Purifiedprotein
from Sephadex G-200 moiety ofPLTP
o  /  o /
/o /o
PE
Lyso PE
rc
Lyso PC
PS
L5no PS
PA
PI
Sphingomyelin
Nr (cL?)
NI (3 spots)
15.6
66.4
5.3
7.4
O*"
5.3
trace
15.4
64.9
6.5
6.8
_
trace
s.4
0.9
13.7
2.6
6.2
t . 8
38.5
5.2
2.5
18.7
0.7
5.2
4.9
16.5
4.r
0.8
33.6
9.0
2.9
19.4
0;2
5 .1
5.2
68.5
24.1
7.4
PE: Phosphatidylethanolamine; PC : phosphatidylcholine; PS : phosphatidylserine;
p[: phosphatidic acid; p1 : phosphatidylinositol; CL : cardiolipin; NI : not identified.
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The extraction of lyophilized porcine lung thromboplastin with n-hep-
tanefn-butanol2ll $lv) as used by Nemerson ll9l to delipidate acetone-
dried bovine lung and brain tissue was more suitable. Besides the neutral
lipids, about 90% of the phospholipids could be extracted (table I)' Thin-
layer chromatography and phosphorus analysis revealed that the remaining
phospholipid content consisted predominantly of phosphatidylserine,
phosphatidylinositol and phosphatidylethanolamine (table II). The solu-
bility of the heptane/butanol-extracted thromboplastin was low in Veronal-
chloride buffer (I 0.015, pH 7.35) but could be markedly increased by the
addition of sodium deoxycholate (l%).
Pwrification by Gel Filtration
Gel filtration of solubilized heptane/butanol-extracted porcine lung
thromboplastin on Sephadex G-200 in the presence of 0.25 | sodium deoxy-
cholate resulted in an elution pattern as shown in figure l. The protein
material was regained almost entirely in one peak, while most of the phos-
phorus-containing components were eluted in two peaks which were se-
parate from the protein peak. These two phosphorus peaks were found to
contain lipid-phosphorus (fractions 26-40) and non-lipid-phosphorus (frac-
tions 41-53). Recombination of each fraction with the phospholipid mix-
ture of thromboplastin showed that the protein moiety of thromboplastin
was localized mainly in the second part of the protein peak corresponding
with a molecular weight of about 300,000. The recovery of the activity was
rather low (10-15 %). However, it was demonstrated that this was not due
to inactivation but to the phospholipid mixture of thromboplastin which
did not fulfil the lipid requirements of the protein for maximum activity' A
3- to 4-fold increase in the recombinant activity could be obtained by en-
richment of this mixture with phosphatidylserine [29]. The lipid-phos-
phorus content of the pooled active fractions amounted to 0.42 prg phos-
phorus per milligram protein. This corresponds to about 1f phospholipid
(table I) consisting predominantly of phosphatidylserine and phosphati-
dylinositol (table II). Removal of deoxycholate by dialysis against buffers
with a pH above 7 always resulted in clear solutions. Lyophilizrtion of this
solution yielded a protein preparation which exhibited a rather low solu-
bility in detergent-free media. However, concentration by dialysis against
l0l polyethylene glycol (molecular weight 20,000) was a suitable following
step.
To achieve a better resolution in the protein peak, Sepharose 6B was
tested. Here, the protein material appeared as two peaks with the highest
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Fig. I. Gel filtration of delipidated porcine lung thromboplastin on sephadex G-200
in the presence of0.25/" sodium deoxycholate.
*  FRACTION
Fig.2. Gel filtration of delipidated porcine lung thromboplastin on sepharose 68 in
the presence of0.25'/" sodium deoxycholate.
specific activity of the protein moi4y of thromboplastin being localized in
the second half of the second protein peak (fractions 24_33; fig.2). On
analytical electrophoresis, the number of protein bands in the combined
active f,ractions was not smaller than was found with sephadex G-200(fig. 3). Furthermore, there was some overlap by the phospholipid peak
(fractions 25-39) whiqh adversely affected the ripid content of the partially
purified protein moiety of thromboplastin. The presence of Rheomacrodex
(21) during the separation'had not the influence on the elution charac-
teristics it was reported to have [14].
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Fig.3, Polyacrylamide gel electrophoresis in the presence ot0.l/" sodium dodecyl
phate, A : n-Heptaneln-butanol-extracted porcine lung thromboplastin; B, C, D :
tially purified protein moiety of porcine lung thromboplastin obtained after gel
on Sephadex G-200, Sepharose 6B and Sepharose 6B+2% Rheomacrodex, respecti
E, F, G : first, second and third peak obtained after gel filtration of A on Bio-Gel A-1.5
in the presence of O.ll sodium dodecyl sulphate.
Purification by Other Frotein Fractionation Techniques
The purified protein moiety of thromboplastin obtained after gel fllt
tion on Sephadex G-200 was used for further purification by other
ques. For that purpose, the preparation was subjected to ammonium su
phate precipitation atpH7.0, chromatography on QAE-Sephadex A-50
pH 7.4 with a linear gradient from 0 to 0.5 u NaCl, chromatography
hydroxylapatite at pH 6.8, preparative gel electrophoresis in 3.75 % poly-
acrylamide at pH 7.35 and isoelectric fractionation. However, none of these
techniques was effective in further purifying the partially purified protein
moiety. Isoelectric focusing showed the thromboplastin protein moiety to
be present in the main protein peak at pH 4.8-5.2.
Formation and Dissociation of Protein Aggregates
The pattern obtained by analytical polyacrylamide gel electrophoresis of
the partially purified protein moiety of thromboplastin showed some protein
material migrating diffusely into the gel and much protein at the top of the
gel. This observation and those ofthe other fractionation techniques suggest
that the purified protein moiety consisted of aggregates. This prompted us
to study the effect of various dissociating agents on the aggregates using
different techniques. Optimal dissociation was achieved in the presence of
277Porcine Tissue Thromboplastin
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Fie. 4. Gel filtration of dodecyl $ulphate-protein complexes of purified protein
of porcine lung thromboplastin onBio-GeI A-1.5 m in the presence of O.l% sodium
decyl sulphate.
sodium dodecyl sulphate (table III). Disc electrophoresis in the presence
0.1t dodecyl sulphate demonstrated 9 bands after staining of the gel w
Coomassie brilliant blue R-250 (fig. 3). No influence on the number or
position of the bands by reduction with 2-mereaptoethanol was found.
was impossible to scale up the analytical polyacrylamide gel e
to a preparative level owing to the formation of a precipitate at the ca
which was'accompanied by a very large increase in the electrical resi
of the system. Gel fitrtration of the dodecyl sulphate-protein complexes
successful when a Bio-Gel A-1.5 m column was used (fig.4). Three
containing only a few protein bands were found (fig. 3); the fourth
fractions 3544, did not contain protein material. Dodecyl sulphate
be completdy removed from the fractions by the method of WsBsx.
KursR. l27l,ba1, following their renaturation procedure, none of the
fractions demonstrated thtomboplastin activity after relipidation.
Discussion
According to Hecur [11] and HBcnr and OosrepsAAN-vAN Ltr [12], the
lipoprotein nature of tissue thromboplastin is disputable. The properties of
the protein fraction of porcine lung thromboplastin as observed in this study
strongly indicate that protein material is responsible for the high clot-pro-
moting activity after recombination with phospholipids.
Porcine Tissue Thromboplastin
Attempts to delipidate and to purify this protein were not completely
successful. Several organic solvent systems which did not destroy the pro-
coagulant property of the protein failed to completely extract the lipids of
lyophilized thromboplastin. One of the best was n-heptanef n-butanol2ll
(v/v); however, some phospholipid, predominantly phosphatidylserine, phos-
phatidylinositol and phosphatidylethanolamine, remained bound to the pro-
tein (tables I, If.
Considerable removal (7 5 %) of the residual phospholipids was achieved
by the use of sodium deoxycholate to solubilize the protein fraction and
during gel filtration on Sephadex G-200. Phosphorus-containing non-lipid
material, probably polynucleotides, was also removed by this method. The
number of protein components in the combined fractions which were active
after recombination was markedly decreased after gel filtration (fig. 3). We
could not improve the separation by using Sepharose 6B or by the addition
of Rheomacrodex to the chromatography system [14]. The residual phos-
pholipid in the partially purified protein moiety of porcine lung thrombo-
plastin was up to 7 times less than in purified protein moieties prepared by
others.
Further purification of the partially purified protein obtained after gel
filtration on Sephadex G-200 was not successful. The active protein pre-
paration contained aggregates consisting of at least 9 different proteins,
as shown by polyacrylamide gel electrophoresis in the presence of dodecyl
sulphate. The occurrence of aggregates is to be expected, in view of the
hydrophobic nature of these proteins. In addition, the residual phospholi-
pids in the protein preparation (about I.OI) may play a role in the forma-
tion of the aggregates. Only dodecyl sulphate was capable of splitting the
aggregates into their constituent proteins. The use of dodecyl sulphate
resulted in the formation of dodecyl sulphate-protein complexes which
could be separated by gel flltration on Bio-Gel A-1.5 m (fig. a). The clot-
promoting property of the protein moiety of thromboplastin was not restored
after removal of dodecyl sulphate from the fractions and renaturation ac-
cording to the method of Wnsnn and KurBn [27]. These findings indicate
that it is necessary to develop a suitable procedure for renaturation of the
protein moiety of lung tissue thromboplastin to complete the final step in the
purification of the protein.
Most of these findings are in general agreement with observations on
the purification of the protein moieties of thromboplastin from other tissues
12,9, 10, 15,20,211. The protein moiety of porcine lung thromboplastin
differs from that of human brain thromboplastin with respect o the effect of
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dodecyl sulphate, thus preventing the use of this detergent in the pu
tion procedure. Different values, ranging from 47,000 to 330,000, have
reported for the molecular weights of the thromboplastin protein moi
The molecular weight of the porcine lung protein (about 300,000)
roughly the same as that of one protein found in a bovine lung prepara
(molecular weight 330,000) [21].
However, an observed molecular weight will strongly depend on
appearance of aggregates. This possibly explains the difference in the
cular weight of the protein moiety of human brain thromboplastin obse
by Bromrro et al. l2l (molecular weight 53,000) and by GoNuonI a
TArnol, [10] (molecular weight 200,000). The same might apply to t
molecular weight of the protein moiety of bovine lung thrombopla
found by Nur,rBnsoN and PITLICK [21] (molecular weight220,000 and 330,
an by Lru and McCov [15] (molecular weight 56,000).
Our results demonstrate that the purification of the protein moiety
porcine lung thromboplastin (and probably also of other thromboplastins)
is complicated by the occurrence of the protein in aggregates with other
proteins. In this respect, the use of incorrect methods to check the homo-
geneity of such a preparation can show a single protein which is only ap-
parent. A procedure which dissociates these aggregates without denaturation
of the protein or an effective renaturation method should be developed to
complete the purification.
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